Topics

XL-protein GmbH Company Profile

03:28 EST 24th January 2020 | BioPortfolio

XL-protein is a privately owned biopharmaceutical company based in Freising, Germany, which exploits its proprietary PASylation® technology to develop biologics with extended plasma half-life and enhanced in vivo activity. PASylation is a fully biological technology that can be applied both to approved biopharmaceuticals to yield second generation drugs ('biobetters') and to innovative therapeutic proteins, peptides or small molecule drugs, thus allowing less frequent and lower dosing combined with better patient tolerability. XL-protein pursues the preclinical and the clinical development of PASylated biologics in commercially attractive disease areas. Furthermore, XL-protein is engaged in collaborations with the Pharma and Biotech industry and offers licenses.


News Articles [1048 Associated News Articles listed on BioPortfolio]

Marinomed-Aktionäre platzieren bis zu 105.000 Aktien

Bei Marinomed kommt er erneut zu einem Aktienverkauf. Die Gesellschaften Acropora Beteiligungs GmbH, VETWIDI Forschungsholding GmbH und BVT Beteiligungsverwaltung und Treuhand GmbH bieten im Wege e...

Marinomed-Aktien erneut zu 95,0 Euro platziert

Die Marinomed-Aktionäre Acropora Beteiligungs GmbH, VETWIDI Forschungsholding GmbH und BVT Beteiligungsverwaltung und Treuhand GmbH haben im Wege eines Accelerated Bookbuildings ins Summe 105.000 A.....

Protein-Protein Interactions Get a New Groove On

New tools can evaluate multiple protein–protein interactions at once, expediting drug screening, filling in interactomes, and revealing patterns of molecular activity as intricately choreographed as...

Osteolabs GmbH receives major contract

osteolabs GmbH announced the successful closing of its first commercial agreements for Germany and Turkey. For Germany, the company has signed up with Eurofins LifeCodexx GmbH as exclusive partner in ...

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

Icky Sticky: Heat Shock Protein Contamination during Protein Purification

Purifying a new protein is no easy feat. Finding combinations of protein purification buffer, salt, detergent, and stabilizing agent to get high yields of squeaky-clean protein can become tedious. Few...

Marinomed Biotech: Aktionäre platzieren Anteile

Drei Großaktionäre von Marinomed Biotech wollen Aktien des Unternehmens platzieren: Acropora Beteiligungs GmbH, VETWIDI Forschungsholding GmbH und BVT Beteiligungsverwaltung und Treuhand GmbH haben....

Laufende Fusionskontrollverfahren: Capgemini Deutschland GmbH, Berlin; Erwerb von Vermögensteilen der Bayer Business Services GmbH, Leverkusen

Datum der Anmeldung:11.12.2019Aktenzeichen:B7-253/19Unternehmen:Capgemini Deutschland GmbH, Berlin; Erwerb von Vermögensteilen der Bayer Business Services GmbH, LeverkusenProduktmärkte:IT-Dienstlei....

Drugs and Medications [15 Associated Drugs and Medications listed on BioPortfolio]

La prairie switzerland [juvena produits de beaute gmbh]

Package.Label Principle Display Panel

Tobramycin [holopack verpackungstechnik gmbh]

Tobramycin Inhalation Solution (300 mg/5 mL)

Lonhala [holopack verpackungstechnik gmbh]

Glycopyrrolate Inhalation Solution (25 µg/mL)

Etoposide [thymoorgan gmbh pharmazir & co. k.g]

Etoposide Injection, USP

Oxygen [metro aire ltd]

Oxygen

PubMed Articles [1837 Associated PubMed Articles listed on BioPortfolio]

In silico evidence that protein unfolding is as a precursor of the protein aggregation.

We present a computational study on the folding and aggregation of proteins in an aqueous environment, as a function of its concentration.  We show how the increase of the concentration of individual...

Varifocal Versus Monofocal LASIK in Presbyopic Hyperopic Eyes.

To compare varifocal (SupraCor; Technolas Perfect Vision GmbH, Munich, Germany) to monofocal (Zyoptix TissueSaving; Bausch & Lomb, Rochester, NY) LASIK in patients with hyperopic presbyopia.

Graphene oxide disrupts the protein-protein interaction between Neuroligin/NLG-1 and DLG-1 or MAGI-1 in nematode Caenorhabditis elegans.

Graphene oxide (GO) is a carbon-based engineered nanomaterial (ENM). Using Caenorhabditis elegans as an animal model, we investigated the effect of GO exposure on protein-protein interactions. In nema...

DISPOT: A simple knowledge-based protein domain interaction statistical potential.

The complexity of protein-protein interactions (PPIs) is further compounded by the fact that an average protein consists of two or more domains, structurally and evolutionary independent subunits. Exp...

Serum calretinin as an independent predictor for platinum resistance and prognosis in ovarian cancer.

Calretinin (CRT) is a calcium-binding protein that controls intracellular calcium signaling. Besides its prominent expression in neurons, serum CRT (sCRT) has recently been suggested as blood-based bi...

Clinical Trials [2703 Associated Clinical Trials listed on BioPortfolio]

Evaluation of Physiological Responses at the Anterior Surface of Two (Hydrophobic Acrylic) Intraocular Lens Models

On the day of surgery, the the eye with astigmatism of at least 0.75dpt receives a Vivinex XY1A , HOYA Surgical Optics GmbH and the second eye to be operated receives an XY1, HOYA Surgical...

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Impact of Cardiac Surgery With a Minimal Invasive Extracorporeal Circuit οn Coagulation: Data From Point of Care Devices

This study includes patients undergoing elective cardiac surgery on MiECC. Coagulation status is assessed with ROTEM (TEM International GmbH, Munich, Germany) and Platelet function with im...

Role of Dietary Protein Intake in Elderly Adults

The investigators examined the effects of dietary protein intake in a mixed meal at two levels of protein amount on whole body protein metabolisms in older adults.

Replacing Protein Via Enteral Nutrition in a Stepwise Approach in Critically Ill Patients

In this study, we will explore the feasibility of doing a randomized controlled trial in our Intensive care department, King Abdulaziz Medical City, Riyadh which will test a two-step appro...

Companies [1333 Associated Companies listed on BioPortfolio]

ProQinase GmbH

ProQinase GmbH was founded in 2001 as a 100% subsidiary of the Tumor Biology Center Freiburg, which is one of the largest privately owned hospitals of this type in Europe. ProQinase has been growing s...

Proteros biostructures GmbH

"Proteros biostructures GmbH, Martinsried, is Europes most experienced and largest company focusing on X-ray protein structure analysis. Successful in business since 1998, Proteros collaborates now wi...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

XL-protein GmbH

XL-protein is a privately owned biopharmaceutical company based in Freising, Germany, which exploits its proprietary PASylation® technology to develop biologics with extended p...

LOGOPHARM GmbH

LOGOPHARM GmbH is a research-oriented biotech company that provides specialized services in proteomic target and biomarker R&D. The company located at Freiburg (Germany) was found by a team of scienti...

More Information about "XL-protein GmbH" on BioPortfolio

We have published hundreds of XL-protein GmbH news stories on BioPortfolio along with dozens of XL-protein GmbH Clinical Trials and PubMed Articles about XL-protein GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of XL-protein GmbH Companies in our database. You can also find out about relevant XL-protein GmbH Drugs and Medications on this site too.

Quick Search

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...


Corporate Database Quicklinks



Searches Linking to this Company Record